Sunosi™ (solriamfetol) – New orphan drug approval
March 20, 2019 - Jazz Pharmaceuticals announced the FDA approval of Sunosi (solriamfetol), to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).
Download PDF
